GO
Loading...

Biogen barreling down on Alzheimer's

Wednesday, 23 Apr 2014 | 3:33 PM ET

CNBC's Meg Tirrell speaks with George Scangos, Biogen Idec CEO, about the drug maker's fight against MS and Alzheimer's. Scangos also comments on Valeant's bid for Alllergan.